25 results on '"Tonato M"'
Search Results
2. p53 overexpression predicts the resistance to chemotherapy in advanced non small cell lung cancer (NSCLC)
3. Randomised phase II study of BMS-275291 versus placebo in patients (pts) with stage IIIb or IV non small cell lung cancer (NSCLC) receiving paclitaxel + carboplatin (PC): National Cancer Institute of Canada clinical trials group (NCIC CTG) br.18
4. Phase II trial of BBR3464, a novel, bifunctional platinum analog, in advanced but favorable out-come, Non Small Cell Lung Cancer patients
5. Post-operative treatments in resected NSCLC
6. P86 Epirubicin as a single agent in comparison to CMF in adjuvant therapy of stage I and II breast cancer
7. The role of neoadjuvant and adjuvant chemotherapy in non-small cell lung cancer
8. Drug utilization for prevention of chemotherapy (CT)-induced emesis
9. Gemcitabine in advanced pancreatic cancer: A phase II trial
10. Intensified chemotherapy with carboplatin and VP-16+G-CSF after induction with cyclophosphamide, epirubicln and vincristine (CEV) in extensive small cell lung cancer (SCLC). A phase II trial
11. 5-HT3 receptor antagonists: Differences and similarities
12. Combination therapy with gemcitabine in non-small cell lung cancer
13. Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
14. 1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
15. European School of Oncology First Euro-American Forum on Lung Cancer Treatment
16. A phase II trial of induction chemotherapy followed by intensification with high-dose (H.D.) chemotherapy or concurrent chemo-radiotherapy and recombinant G-CSF in extensive (E.D.) and limited (L.D.) small cell lung cancer (SCLC)
17. Persistence of efficacy of ondansetrom (DMD) plus dexanethasone (DEX) VS metoclopramide (MTC) plus dex and diphennydramine (DIP) in acute emesis during three consecutive cycles of cisplatin (CDDP) chemotherapy (CT)
18. Confirmatory activity of gemcitabine in non small cell lung cancer (NSCLC)
19. Supportive therapy: Challenges for the '90s—Perspectives in antiemetic therapy
20. The Perugia international cancer conference III Introduction
21. Supportive therapy: Challenges for the '90s—Perspectives in antiemetic therapy
22. 1266 - Gemcitabine in advanced pancreatic cancer: A phase II trial
23. 1058 - Intensified chemotherapy with carboplatin and VP-16+G-CSF after induction with cyclophosphamide, epirubicln and vincristine (CEV) in extensive small cell lung cancer (SCLC). A phase II trial
24. 1019 - The role of neoadjuvant and adjuvant chemotherapy in non-small cell lung cancer
25. 69 - Drug utilization for prevention of chemotherapy (CT)-induced emesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.